Kodessa Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 13-01-2025
- Paid Up Capital ₹ 0.10 M
as on 13-01-2025
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.00 M
as on 13-01-2025
- Revenue -28.04%
(FY 2022)
- Profit -88.15%
(FY 2022)
- Ebitda 72.64%
(FY 2022)
- Net Worth 9.98%
(FY 2022)
- Total Assets -45.18%
(FY 2022)
About Kodessa Pharmachem
The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹4.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Gaurang Patel and Jayshree Patel serve as directors at the Company.
- CIN/LLPIN
U24299GJ2020PTC118258
- Company No.
118258
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Nov 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kodessa Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurang Patel  | Director | 16-Nov-2020 | Current |
| Jayshree Patel | Director | 16-Nov-2020 | Current |
Financial Performance of Kodessa Pharmachem.
Kodessa Pharmachem Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 28.04% decrease. The company also saw a substantial fall in profitability, with a 88.15% decrease in profit. The company's net worth moved up by a moderate rise of 9.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kodessa Pharmachem?
Unlock access to Kodessa Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Feb 2023 | ₹4.00 M | Satisfied |
How Many Employees Work at Kodessa Pharmachem?
Kodessa Pharmachem has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kodessa Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kodessa Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
